Harnessing the power of phage for unparalleled diagnostic sensitivity
We are powering the next generation of point-of-care diagnostic tools
Using our patented technology, Nanophage Technologies Ltd design and synthesize custom nano-scale phage particles for diagnostic tools aimed at identifying molecules of interest with high sensitivity for fast, accurate, and early diagnosis. Our technology is applicable to a wide variety of environmental, agricultural, food and medical samples.
Who we are
Our team of scientists have dedicated over 10 years in the design and development of this breakthrough nanorod technology to advance science and revolutionize the world of diagnostics.
Utilize the power of Nanorods
We are currently validating our Nanorods for use in the following applications:
Fluorescent Nanorods for flow cytometry, fluorescence microscopy
Enzyme-labelled Nanorods for ELISA, immunohistochemistry
Highly-sensitive Nanorods for advanced custom diagnostics
Have a read of the latest news from Nanophage Technologies!
Our Partnerships
In Partnership
Nanophage Technologies is proudly supported by Bridgewest Ventures NZ LP. Bridgewest Ventures is part of the Bridgewest Group and has a long track record of successfully incubating and launching major global innovation-led companies. Bridgewest’s deep technology experience is wide-ranging and includes biotech and the health sector. Bridgewest Ventures leverage their extensive connections, international reach, and commercialisation experience to transform innovative opportunities into world-class companies.
Fostering innovation in NZ
We are proud to be part of Callaghan Innovation’s Technology Incubator Programme. Callaghan Innovation is New Zealand’s innovation agency. It activates innovation and helps businesses grow faster for a better New Zealand. The government agency delivers a range of innovation and R&D services to suit each stage of business growth. Its staff – including more than 200 of New Zealand’s leading scientists and engineers – empower innovators by connecting people, opportunities, and networks and providing tailored technical solutions, skills and capability development programmes, and grants co-funding.
Partnering with us
Nanophage Technologies is working in partnership with Massey Ventures Limited , a wholly-owned subsidiary of Massey University, Palmerston North, New Zealand, whose role is to commercialise intellectual property and innovative research within the University. They work with Massey researchers and inventors to guide them through the commercialisation process and turn their innovative ideas into real-world commercial opportunities connecting them to early-stage investment to accelerate their innovation to global markets.
Interested in investment? Visit our For Investors page to learn more
Get in touch
We’d love to hear from you.